0001209191-16-150139.txt : 20161115
0001209191-16-150139.hdr.sgml : 20161115
20161115160521
ACCESSION NUMBER: 0001209191-16-150139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161114
FILED AS OF DATE: 20161115
DATE AS OF CHANGE: 20161115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frenkel Ran
CENTRAL INDEX KEY: 0001623108
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 161999724
MAIL ADDRESS:
STREET 1: KARYOPHARM THERAPEUTICS, INC.
STREET 2: 85 WELLS AVENUE, 2ND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-14
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001623108
Frenkel Ran
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
0
1
0
0
Chief Dev Operations Officer
Common Stock
2016-11-14
4
S
0
3309
10.0593
D
14691
D
This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.13, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Christopher B. Primiano as attorney-in-fact for Ran Frenkel
2016-11-15